Open research questions in COVID-19 epidemiological studies
66 unresolved questions extracted from the limitations and future-work sections of 1,085 COVID-19 epidemiological studies papers in our library. Each links back to the study that raised it.
What the literature leaves open
These improvements suggest that the posterior geometry, rather than methods alone, leads to robust inference in the parameter space and model choices should be investigated as thoroughly as tuning of methods. Supplementary Results SEIR-Model with Sparse Data.
Assessment of simulation-based inference methods for stochastic compartmental models in epidemiological research · 2026 · DOIA key limitation is that the model was validated against city-level first arrival times rather than full epidemic dynamics, and was parameterised using mobility data from China’s “dynamic zero-COVID” period, which may limit direct quantitative generalisability to other settings.
Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study · 2026 · DOITransmission heterogeneity (superspreading) is recognised in Ebola epidemics, but empirical estimates of its extent and determinants remain scarce for DRC outbreaks.
Quantifying the heterogeneity and determinants of Ebola Zaire transmission during the 10th outbreak in DRC, 2018-2020. · 2026 · DOIABSTRACT While existing work shows COVID‐19 stay‐at‐home (SAH) policies decreased mobility on average, we lack evidence regarding heterogeneity in policy effectiveness across US counties.
Deniers and Compliers: Unpacking the Heterogeneous Effectiveness of U.S. Stay‐at‐Home Mandates During the COVID‐19 Pandemic · 2026 · DOIIn addition, the results show that it is insufficient to restrict the movements of infected cattle on Öland to bring $R_t < 1$, as local spread and within-herd transmission contribute equally to the force of infection (approximately 50% each).
Bayesian modelling of herd-level infection dynamics in cattle: Local spread as the primary driver of Salmonella Dublin persistence on Öland · 2026Improving indoor air quality (IAQ) therefore could help reduce disease burden associated with respiratory viruses, yet its population-level impact remains poorly quantified.
Modelling the public-health impact of indoor air quality interventions on respiratory virus transmission · 2026 · DOIHowever, such data are often subject to a “day-of-the-week effect” (DOWE), whereby the number of cases on certain days of the week is liable to being under-reported (due to administrative delays) or over-reported (as public health authorities “catch-up” on reporting delayed cases).
Robust estimation of the time-dependent reproduction number in the presence of weekend reporting effects · 2026 · DOIReal-time compliance estimates from community surveys on testing and isolation uptake across fine-scale geographical levels and sociodemographic groups require improved integration into behaviour and disease (BaD) models. Specific work is needed to develop methods for onboarding survey-based compliance data to enhance the model's ability to predict impactful testing interventions.
The model does not incorporate severe case outcomes (hospitalisations and deaths) despite population perception of illness threat potentially varying by case severity over an outbreak. Refinement is needed to include hospitalisation and death dynamics, with parameterisation of how the population's behavioural response shifts when attributed different importance to cases versus hospitalisations versus deaths.
The model is restricted to a single pathogen strain and one disease control intervention (testing). The consideration of multiple strains/variants in conjunction with multiple non-pharmaceutical interventions (NPIs) such as social distancing and mask-usage, and their combined behavioural and epidemiological feedbacks, requires model extension and appropriate parameterisation of behaviour-disease interactions.
Parameter estimation for test-seeking propensity currently relies on coarse demographic-level public health agency data (e.g., weekly testing reports). Enhanced estimation requires pseudonymised individual-level data capturing multiple influences on testing uptake including employment conditions, geographical location, population density, beliefs about testing, health literacy, deprivation indices, age, and gender, which should be accessed through secure data environments.
The model implements idealised testing conditions with no delays in test accessibility, availability, or supply constraints. Future modelling should incorporate empirical data on test supply limitations and investigate the cascading effects on infectious prevalence when individuals cannot access tests and do not self-isolate, as well as the negative feedbacks on testing uptake for future infection episodes.
The model assumes symptomatic individuals who tested negative retained the same infectiousness and behaviour as untested symptomatic individuals, despite test sensitivity being below 100%. Removing this assumption requires behavioural data collection on how negative test results affect behaviour change, infectiousness reduction, and compliance in symptomatic 'behaviour aware' individuals.
The model assumes fixed values for behaviour effect parameters (ω1, ω2, ω3) and testing behaviour abandonment rates (α1, α2), preventing temporal variation in behavioural factors. Specifically, the decay rate on perception of illness threat (ω2) should be parameterised to represent growing normality through time as cases circulate in the community, and different reporting lags for positive test counts could be applied to the epidemiological metric tied to perception of illness threat.
Policy frameworks linking local, national, and global AI-driven surveillance initiatives (as illustrated in Figure 4) are conceptually described, but concrete mechanisms for enforcing policy alignment across multi-level governance structures and resolving conflicts between data ownership, privacy, and innovation remain undefined.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOICombining climate variables with health records has revealed early-warning indicators for vector-borne diseases like malaria and dengue, but the fusion of environmental data with hospital admissions and mobility patterns for multi-pathogen outbreak detection in diverse geographic regions lacks validation across endemic zones.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOIThe capacity-building gap in low- and middle-income countries requires empirical evaluation of equitable funding models, knowledge transfer mechanisms, and technology transfer protocols that would enable adoption of AI-driven epidemiological modeling systems, yet specific implementation pathways remain unspecified.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOIReal-time global pandemic preparedness systems require continuous integration of clinical records, social media signals, mobility flows, and genomic surveillance data into adaptive forecasting engines, but the technical readiness of such real-time architectures for coordinated multi-source data ingestion remains underdeveloped.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOITransformer-based models, graph neural networks, and reinforcement learning frameworks have shown superior performance for infectious disease forecasting, but their computational demands create barriers to equitable deployment across low- and middle-income countries lacking cloud infrastructure and computing resources.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOIPrivacy-preserving architectures for federated and edge AI in infectious disease surveillance remain underspecified for environments with varying regulatory landscapes (e.g., GDPR compliance versus national health data policies), requiring concrete implementation protocols for collaborative learning across heterogeneous governance structures.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOIUniversal coding standards and database formats are needed to enable AI models to integrate clinical, mobility, and genomic data seamlessly across national boundaries, but no consensus framework currently balances flexibility with enforcement requirements for global predictive surveillance systems.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOIMultimodal fusion models must develop robust pipelines to manage missing data, noise, and variable reliability across disparate clinical, mobility, and environmental data sources at scale, yet current approaches lack standardized reproducibility frameworks for large-scale integration of these heterogeneous datasets.
Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · 2026 · DOI<ns3:p> <ns3:bold>Background</ns3:bold> : Mobility restrictions prevent the spread of infections to disease-free areas, and early in the coronavirus disease 2019 (COVID-19) pandemic, most countries imposed severe restrictions on mobility as soon as it was clear that containment of local outbreaks was insufficient to control spread.
SCoVMod – a spatially explicit mobility and deprivation adjusted model of first wave COVID-19 transmission dynamics · 2022 · DOIThe consequences of the route to deterministic chaos in epidemic dynamics are acknowledged as 'worth being studied,' but the paper does not specify which consequences (e.g., intermittent superspreading events, critical transitions in transmission networks, or resonance with population mobility patterns) should be prioritized for investigation.
The paper demonstrates that rapid release of containment measures can trigger strong instabilities with chaotic variations in hospital bed demand, but does not provide specific quantitative thresholds for the rate of R0 increase (dR0/dt) that would maintain system stability versus crossing into multi-stable or chaotic regimes.
Most-cited papers in COVID-19 epidemiological studies
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia · New England Journal of Medicine · 2020 · 11,550 citations
- Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study · The Lancet · 2020 · 3,500 citations
- The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak · Science · 2020 · 2,951 citations
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) · Science · 2020 · 2,751 citations
- How will country-based mitigation measures influence the course of the COVID-19 epidemic? · The Lancet · 2020 · 2,724 citations
- The effect of human mobility and control measures on the COVID-19 epidemic in China · Science · 2020 · 2,363 citations
- Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing · Science · 2020 · 2,098 citations
- Coronavirus Infections—More Than Just the Common Cold · JAMA · 2020 · 1,449 citations
- Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China · JAMA · 2020 · 1,334 citations
- COVID-19: the gendered impacts of the outbreak · The Lancet · 2020 · 1,230 citations
Most recent work
- Who infected the reported cases? Evidence from 678,482 COVID-19 cases with identified infector collected in routine surveillance in the Netherlands, 2020-2022. · medRxiv · 2026
- Scalable calibration of individual-based epidemic models through categorical approximations · Journal of the American Statistical Association · 2026
- Ebola outbreak: 139 dead as WHO warns of “scale and speed” of spread in central Africa · BMJ · 2026
- A risk-of-contagion index using a Bayesian based model for the COVID-19 epidemic in Mexico · medRxiv · 2026
- Interpreting Breakthrough Infections Given Assortative Mixing of Partially Vaccinated Populations · medRxiv · 2026
- From Outbreak to Endemicity or Control: Tracking First Passage Time in Infectious Diseases · Bulletin of Mathematical Biology · 2026
- Integrating multimodal health datasets with AI-driven epidemiological modeling to accurately forecast infectious disease transmission across populations · Magna Scientia Advanced Biology and Pharmacy · 2026
- Complex Structure in the Endemic Equilibrium Set of an SIS Epidemic Patch Model with the Mass-Action Infection Mechanism · SIAM Journal on Applied Mathematics · 2026
- A behaviour and disease model of testing and isolation · Mathematics in Medical and Life Sciences · 2026
- Multitype SIR epidemics among a population partitioned into households with proportionate global mixing · Journal of Mathematical Biology · 2026
Find a gap in your own COVID-19 epidemiological studies sub-topic
This page shows what the COVID-19 epidemiological studies literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →